Cortisol Metabolism in Human Obesity: Impaired Cortisone→Cortisol Conversion in Subjects with Central Adiposity1
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
For a given body mass index (BMI), mortality is higher in patients with central compared to generalized obesity. Glucocorticoids play an important role in determining body fat distribution, but circulating cortisol concentrations are reported to be normal in obese patients. Our recent studies show enhanced conversion of inactive cortisone (E) to active cortisol (F) through the expression of 11beta-hydroxysteroid dehydrogenase type 1 (11betaHSD1) in cultured omental adipose stromal cells; the autocrine production of F may be a crucial factor in the pathogenesis of central obesity. We have now analyzed F metabolism in subjects with BMIs between 20-25 kg/m2 (group A), 25-30 kg/m2 (group B), and more than 30 kg/m2 (group C; n 12 in each group; six males and six premenopausal females; aged 23-44 yr). Glucose/insulin were measured using a 75-g oral glucose tolerance test, and each subject had total body and regional fat (scapular, waist, hip, and thigh) quantified using dual energy x-ray absorptiometry. Urinary total F metabolites (measured by gas chromatography/mass spectrometry) were increased in subjects with obesity [group A, 11,176 +/- 1,530 microg/24 h (mean +/- SE); group C, 13,661 +/- 1,444], although not significantly so (P = 0.08). There was a significant reduction in the urinary tetrahydrocortisol (THF) +/- 5alpha-THF/tetrahydrocortisone (THE) and the cortol/cortolone ratio in obesity (group A vs. C, 1.06 +/- 0.08 vs. 0.84 +/- 0.04 and 0.41 +/- 0.03 vs. 0.34 +/- 0.03, respectively; both P < 0.05). Urinary free F (UFF) excretion was similar in all three groups, as was the UFF/urinary free E (UFE) ratio. The 0900 h circulating F, E, and ACTH pre- and postovernight 1-mg dexamethasone suppression values were similar in all three groups, but a reduction in the generation of serum F from dexamethasone-suppressed values after oral cortisone acetate (25 mg) was evident in both obese groups [e.g. 546 +/- 37 nmol/L in group A vs. 412 +/- 40 in group B (P < 0.05) and 388 +/- 38 in group C (P < 0.01) 180 min post-E]. Insulin resistance was present in groups B and C, but regression analysis revealed no relationship between F metabolites or the THF +/- 5alpha-THF/THE ratio and insulin action (homeostasis model assessment analysis and insulin values in the oral glucose tolerance test). There was, however, a highly significant relationship between the THF +/- 5alpha-THF/THE ratio and BMI (t = -3.44; P < 0.01) and total body fat (t = -2.27; P < 0.05). Stepwise regression analyses indicated an inverse relationship between THF+/-5alpha-THF/THE and scapular and waist fat (t = -2.25; P = 0.03) and a direct relationship with hip and thigh fat (t = 2.42; P = 0.02) in both sexes. The fall in the THF + 5alpha-THF/THE ratio but unchanged UFF/UFE ratio together with impaired F concentrations after oral E indicates inhibition of 11betaHSD1 in subjects with obesity. This results in an increased MCR for F, explaining the increased F secretion rate in obesity in the face of normal circulating F concentrations. 11BetaHSD1 activity is highly related to body fat distribution, with android or central obesity, but not gynoid obesity, associated with reduced activity in both sexes. This reduction in 11betaHSD1 activity raises new questions as to the primary role of 11betaHSD1 in the pathogenesis of insulin resistance and central obesity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As surrogate measures of adverse metabolic risk (27), AVF and omental fat-cell size have been associated in some but not all studies with increased activity or expression of 11β-hydroxysteroid dehydrogenase type 1, which promotes conversion of inactive cortisone to active cortisol (28–31).”
From Glucose ingestion selectively amplifies ACTH and cortisol secretory-burst mass and enhances their joint synchrony in healthy men. (2011) · cites this paper as [31]
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Kotelevtsev, Y., Holmes, M. C., Burchell, A., Houston, P. M., Schmoll, D., Jamieson, P., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 858
Does central obesity reflect “Cushing's disease of the omentum”?
Bujalska, I. J., Kumar, S., & Stewart, P. M. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11222-8 · Cited by 753 · cited 2×
“increased expression of 11bHSD1 in human adipose stromal cells from omental compared with sc depots (21).”
Self-citationSex- and menopause-associated changes in body-fat distribution
Ley, C., Lees, B., & Stevenson, J. (1992) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/55.5.950 · Cited by 733
Cloning and tissue distribution of the human 1 lβ-hydroxysteroid dehydrogenase type 2 enzyme
Albiston, A. L., Obeyesekere, V. R., Smith, R. E., & Krozowski, Z. S. (1994) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)90176-7 · Cited by 712
(1996) · PubMed · Cited by 643
11β-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess*
White, P. C., Mune, T., & Agarwal, A. K. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0288 · Cited by 517
Cortisol secretion in relation to body fat distribution in obese premenopausal women
Mårin, P., Darin, N., Amemiya, T., Andersson, B., Jern, S., & Björntorp, P. (1992) · Metabolism · doi:10.1016/0026-0495(92)90171-6 · Cited by 458
Tannin, G. M., Agarwal, A. K., Monder, C., New, M. I., & White, P. C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55351-5 · Cited by 436
Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.
Stewart, P. M., Corrie, J. E., Shackleton, C. H., & Edwards, C. R. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113592 · Cited by 430
Self-citation
Cited by
Items 301–400 of 415
Espiard, S., McQueen, J., Sherlock, M., Ragnarsson, Ó., Bergthorsdottir, R., Burman, P., Dahlqvist, P. M., Ekman, B., Engström, B. E., Skrtic, S., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa862 · Cited by 15
Self-citationShi, Y., Kim, H., Hamann, C. A., Rhea, E. M., Brunger, J. M., & Lippmann, E. S. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00375-3 · Cited by 15
Wang, Y., Liu, L., Du, H., Nagaoka, Y., Fan, W., Lutfy, K., Friedman, T. C., Jiang, M., & Liu, Y. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00491.2013 · Cited by 15
Chedid, M. F., do Nascimento, F. V., de Oliveira, F. S., de Souza, B. M., Kruel, C. D. P., Gurski, R. R., Canani, L. H. S., Crispim, D., & Gerchman, F. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0474-2 · Cited by 14
Otto, L., Budde, K., Kastenmüller, G., Kaul, A., Völker, U., Völzke, H., Adamski, J., Kühn, J., Krumsiek, J., Artati, A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-58430-8 · Cited by 14
Sex‐specific Difference in the Interconversion of Cortisol and Cortisone in Men and Women
Vierhapper, H., Heinze, G., & Nowotny, P. (2007) · Obesity · doi:10.1038/oby.2007.592 · Cited by 15
Fujisawa, Y., Nakagawa, Y., Li, R.-S., Liu, Y., & Ohzeki, T. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.07.002 · Cited by 14
Physiologic roles of 11β-hydroxysteroid dehydrogenase type 2 in kidney
Isomura, Y., Mune, T., Morita, H., Suwa, T., Takada, N., Yamamoto, Y., & Takeda, J. (2006) · Metabolism · doi:10.1016/j.metabol.2006.06.005 · Cited by 17
Fat Cell‐Derived Modulators of Vascular Cell Pathophysiology: The List Keeps Growing
Marcus, Y., & Stern, N. (2006) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4564.2006.05674.x · Cited by 13
Stimson, R. H., Lobley, G. E., Maraki, I., Morton, N. M., Andrew, R., & Walker, B. R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008779 · Cited by 13
Selective antagonism of the hepatic glucocorticoid receptor reduces hepatic glucose production
Edgerton, D. S., Jacobson, P. B., Opgenorth, T. J., Zinker, B. A., Beno, D. W. A., von Geldern, T., Öhman, L., Scott, M. F., Neal, D. W., & Cherrington, A. D. (2006) · Metabolism · doi:10.1016/j.metabol.2006.05.011 · Cited by 13
Liu, Y., Park, F., Pietrusz, J. L., Jia, G., Singh, R., Netzel, B. C., & Liang, M. (2008) · The FASEB Journal · doi:10.1096/fasebj.22.1_supplement.1162.7 · Cited by 12
Mai, K., Kullmann, V., Bobbert, T., Maser‐Gluth, C., Möhlig, M., Bähr, V., Pfeiffer, A. F. H., Spranger, J., & Diederich, S. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02362.x · Cited by 16
GH effect on enzyme activity of 11βHSD in abdominal obesity is dependent on treatment duration
Sigurjónsdóttir, H. Á., Koranyi, J., Axelson, M., Bengtsson, B., & Johannsson, G. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02061 · Cited by 12
Tagawa, N., Ikariko, N., Fukumura, K., & Yoshiharu, K. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.403 · Cited by 12
Cortisol Levels During an Oral Glucose Tolerance Test in Lean and Obese Women
Çakır, M., Sarı, R., Tosun, Ö., & Karayalçın, Ü. (2005) · Endocrine Research · doi:10.1080/07435800500373199 · Cited by 11
Ragnarsson, Ó., Trimpou, P., Oleröd, G., & Landin‐Wilhelmsen, K. (2015) · Steroids · doi:10.1016/j.steroids.2015.06.007 · Cited by 10
Sex Differences in Energy Balance, Body Composition, and Body Fat Distribution
Tchernof, A. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-250-6_1 · Cited by 13
Li, R.-S., Nakagawa, Y., Nakanishi, T., Fujisawa, Y., & Ohzeki, T. (2004) · Metabolism · doi:10.1016/j.metabol.2003.11.010 · Cited by 10
Morin-Papunen, L. C., Vauhkonen, I., Koivunen, R. M., Ruokonen, A., & Tapanainen, J. S. (2000) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200011000-00017 · Cited by 10
Impact of Adiposity and Fat Distribution on the Dynamics of Adrenocorticotropin and Cortisol Rhythms
Roelfsema, F., Pereira, A. M., & Veldhuis, J. D. (2014) · Current Obesity Reports · doi:10.1007/s13679-014-0118-7 · Cited by 10
Mitchell, J. M., Lyons, H., Walker, J. K., Yiangou, A., Grech, O., Alimajstorovic, Z., Greig, N. H., Li, Y., Tsermoulas, G., Brock, K., et al. (2022) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2022-abn.317 · Cited by 9
Gender difference in adrenal sensitivity to ACTH is abolished in type 2 diabetes
Arnetz, L., Ekberg, N. R., Brismar, K., & Alvarsson, M. (2015) · Endocrine Connections · doi:10.1530/ec-15-0003 · Cited by 9
Paisley, A. N., Rowles, S., Brandon, D. D., & Trainer, P. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2392 · Cited by 9
In Vivo Measurement of Renal 11β-Hydroxysteroid Dehydrogenase Type 2 Activity
Quinkler, M. O., Oelkers, W., & Diederich, S. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7076-3 · Cited by 9
Zuckerman‐Levin, N., Tsivlin, L., Knopf, C. F., Flor, O., Shen‐Orr, Z., Levin, M., & Hochberg, Z. (2011) · Pediatric Research · doi:10.1203/pdr.0b013e3182226a0c · Cited by 8
The Role of 11.BETA.-Hydroxysteroid Dehydrogenases in the Cardiovascular System
Krozowski, Z. S., & Chai, Z. (2003) · Endocrine Journal · doi:10.1507/endocrj.50.485 · Cited by 11
Upregulation of Hepatic 11β-Hydroxysteroid Dehydrogenase-1 Expression in Calcium-Deficient Rats
Takaya, J., Iharada, A., Okihana, H., & Kaneko, K. (2011) · Annals of Nutrition and Metabolism · doi:10.1159/000332915 · Cited by 9
Phillips, D. I. W., Syddall, H. E., Cooper, C. C., & Hanson, M. A. (2008) · American Journal of Human Biology · doi:10.1002/ajhb.20803 · Cited by 8
11β-Hydroxysteroid dehydrogenase type 1 as a therapeutic target in the metabolic syndrome
Tomlinson, J., & Stewart, P. M. (2005) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2005.05.006 · Cited by 8
Self-citationSousa, S., Pestana, D., Faria, G. R., Delerue-Matos, C. M., Calhau, C., & Domingues, V. F. (2023) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2023.102581 · Cited by 7
Sofer, Y., Osher, E., Ahmad, W. A., Greenman, Y., Moshe, Y., Shaklai, S., Yaron, M., Serebro, M., Tordjman, K. M., & Stern, N. (2025) · Obesity Facts · doi:10.1159/000543449 · Cited by 7
Mass spectrometry and its evolving role in assessing tissue specific steroid metabolism
Andrew, R., & Homer, N. Z. M. (2016) · Biochemical Society Transactions · doi:10.1042/bst20150234 · Cited by 9
Kerstens, M. N., Buter, H., Navis, G., & Dullaart, R. P. F. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.01013.x · Cited by 8
Mansour, N., Brüdgam, D., Heinrich, D. A., Dischinger, U., Reisch, N., Völter, F., Stüfchen, I., Nowak, E., Zopp, S., Vasileva, V., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1521680 · Cited by 6
Loerz, C., Staab-Weijnitz, C. A., Huebbe, P., Giller, K., Metges, C. C., Rimbach, G. H., & Maser, E. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.02.018 · Cited by 6
Brossaud, J., Barat, P., & Moisan, M. (2024) · Neuroendocrinology · doi:10.1159/000541989 · Cited by 6
Circulating 11β‐Hydroxysteroid Dehydrogenase Type 1 mRNA and Cardiovascular Risk Factors
Bakir, M. A., Butt, A. N., & Swaminathan, R. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.007 · Cited by 6
Beentjes, J. (2001) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510152379003 · Cited by 7
Vital Role of Visceral Adipose Tissue in Maintaining Cognitive Functions
Shirafuji, R., Amagase, Y., Goto, A., & Takei, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146597 · Cited by 5
Urinary Steroid Excretion Rates in Acromegaly
Vierhapper, H., Nowotny, P., & Waldhäusl, W. K. (2005) · Hormone Research in Paediatrics · doi:10.1159/000085840 · Cited by 5
Šimůnková, K., Hampl, R., Hill, M., Kříž, L., Vrbíková, J., Kvasničková, H., & Vondra, K. (2011) · Physiological Research · doi:10.33549/physiolres.932079 · Cited by 5
Determinación de los niveles de cortisol salival en una muestra de sujetos de Santiago de Chile
Lépez, M., Caamaño, E., Romero, C., Fiedler, J. L., & Araya, V. (2010) · Revista médica de Chile · doi:10.4067/s0034-98872010000200004 · Cited by 15
Are we in danger from an epidemic of Cushing's syndrome? Nature knows its course*
Weaver, J. U. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01422.x · Cited by 5
Bini, J., Strober, J. W., Kapinos, M., Zheng, M., Li, S., Ropchan, J. R., Nabulsi, N., Huang, Y. H., Perry, R. J., Vatner, D. F., et al. (2024) · Molecular Imaging · doi:10.1177/15353508241301584 · Cited by 4
Ryan, V. H., Trayhurn, P., Hunter, L., Morris, P., & German, A. J. (2011) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2011.06.001 · Cited by 5
Steroid Hormones Related to 11β-hydroxysteroid Dehydrogenase Type 1 in Treated Obesity
Máčová, L., SOSVOROVÁ, L., Vítků, J., Bičíková, M., Hill, M., Zamrazilová, H., Sedláčková, B., & Stárka, L. (2015) · Physiological Research · doi:10.33549/physiolres.933073 · Cited by 4
Sandner, B., & Kratzsch, J. (2017) · Journal of Laboratory Medicine · doi:10.1515/labmed-2017-0024 · Cited by 4
Energy expenditure, body composition, and biochemical indicators in healthy community women
Nies, M. A., Chen, K. Y., & Wal, J. S. V. (2004) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637480410001734120 · Cited by 4
Fürst‐Recktenwald, S., Dörr, H. G., Quinkler, M. O., Dötsch, J., & Stewart, P. M. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04406.x · Cited by 3
Self-citationCortisol Responses and Energy Expenditure at Different Times of Day in Obese Vs. Lean Men
Azizi, M., Rahmani‐Nia, F., & Mohebbi, H. (2012) · Cited by 3
Porzezińska-Furtak, J., Krzyżanowska‐Świniarska, B., Miazgowski, T., Ziemak, J., & Widecka, K. (2009) · Endokrynologia, Otyłość i Zaburzenia Przemiany Materii · Cited by 9
Cell-type specific regulation of the human 11beta-hydroxysteroid dehydrogenase type 1 promoter
Andres, J., Mai, K., Möhlig, M., Weickert, M. O., Bumke‐Vogt, C., Diederich, S., Pfeiffer, A. F. H., Bähr, V., & Spranger, J. (2007) · Archives of Physiology and Biochemistry · doi:10.1080/13813450701531219 · Cited by 3
Neurohormonal mechanisms in insulin resistance and type 2 diabetes
Lindmark, S. (2004) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 3
Shen, K., Huang, J., Liu, D., Lu, Q., Kang, X., & Yan, Y. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1784658 · Cited by 2
Sandner, B., & Kratzsch, J. (2017) · Journal of Laboratory Medicine · doi:10.1515/labmed-2017-0004 · Cited by 2
Cognitive Assessment in Adults With Adrenal Cortisol Insufficiency: Challenges and Opportunities
Ben-Shlomo, A., Koh, M., Kremen, S. A., & Wertheimer, J. C. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf029 · Cited by 4
11β-Hydroxysteroid Dehydrogenase Type 1 and the Metabolic Syndrome
Cidalia, D., Maria, J., Azevedo, I., & Monteiro, R. (2011) · InTech eBooks · doi:10.5772/28641 · Cited by 2
Friedman, T. C. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-101-5_15 · Cited by 2
Lipson, V. V., Shirobokova, M. G., & Petrova, O. N. (2013) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-013-0900-y · Cited by 2
Iovino, A., & Scheen, A. J. (2009) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(09)73624-7 · Cited by 2
Diazepane–acetamide derivatives as selective 11β-hydroxysteroid dehydrogenase type 1 inhibitors
Odermatt, A. (2009) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770902911490 · Cited by 2
Klusoňová, P., Pátková, L., Ergang, P., Mikšík, I., Zicha, J., Kuneš, J., & Pácha, J. (2011) · Steroids · doi:10.1016/j.steroids.2011.06.003 · Cited by 2
Rees, M. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9781139696937.002 · Cited by 2
Cortisol Metabolism as a Regulator of the Tissue-Specific Glucocorticoid Action
Sbardella, E., & Tomlinson, J. (2016) · Springer eBooks · doi:10.1007/978-3-319-45950-9_14 · Cited by 3
Plasma Levels of CA125, CEA, AFP and Cortisol in Obesity
BO, A. M. S. (2015) · Journal of Steroids & Hormonal Science · doi:10.4172/2157-7536.1000154 · Cited by 2
El síndrome metabólico como síndrome de Cushing intrahepatocitario
Vázquez, G. F., Torrecilla, E., & Rubio, M. Á. (2011) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2010.12.003 · Cited by 2
Larsson, C. (2011) · Lund University Publications (Lund University) · Cited by 3
Metabolic and Endocrine Physiology in Obesity
Álvarez-Castro, P., Sangiao‐Alvarellos, S., & Cordido, F. (2012) · Wiley eBooks · doi:10.1002/9781119962083.ch4 · Cited by 2
Salivary Cortisol Can Reflect Adiposity and Insulin Sensitivity in Type 2 Diabetes
Matsuzawa, Y., Sakurai, K., Saito, J., Omura, M., & Nishikaw, T. (2011) · InTech eBooks · doi:10.5772/27172 · Cited by 1
Melanocortin system in cancer-related cachexia
Vašků, J. B., Bienert, P., Valík, D., & Vašků, A. (2011) · Open Medicine · doi:10.2478/s11536-011-0057-6 · Cited by 1
Sweat cortisol response to stress, macronutrient consumption and birth control
Tu, E., Begdache, L., Won, D., & Koh, A. (2019) · IEEE Research and Applications of Photonics in Defense Conference (RAPID) · doi:10.1109/rapid.2019.8864374 · Cited by 1
Iovino, A., Paquot, N., & Scheen, A. J. (2009) · Obésité · doi:10.1007/s11690-009-0204-2 · Cited by 1
Martino, J. (2013) · Nottingham ePrints (University of Nottingham) · Cited by 1
11β-Hydroxysteroid Dehydrogenase Type 1 and Obesity
Stimson, R. H., & Walker, B. R. (2007) · Humana Press eBooks · doi:10.1007/978-1-60327-139-4_10 · Cited by 1
Kobayashi, N., Masuzaki, H., Tanaka, T., Yasue, S., Ishii, T., Tomita, T., Miyawaki, T., Komeda, T., Fukuda, Y., Kusakabe, T., et al. (2009) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2008.11.002 · Cited by 1
Stomby, A. (2015) · DiVA at Umeå University (Umeå University) · Cited by 1
Estrogen and Glucocorticoid Metabolism
Andersson, T. (2010) · DiVA at Umeå University (Umeå University)
Inflammation and end-organ damage with obesity and gender
Bloor, I. D. (2012) · Nottingham ePrints (University of Nottingham)
Adipose tissue inflammation, liver fat and insulin resistance in humans
Makkonen, J. (2010) · Työväentutkimus Vuosikirja
Análisis de polimorfismos de genes asociados al síndrome metabólico en niños obesos
Olza, J. (2011) · Institutional Repository of the University of Granada (University of Granada) · Cited by 1
11β‐Hydroxysteroid Dehydrogenase Type 1 as a Therapeutic Target for Type 2 Diabetes
Hale, C., & Jean, D. J. S. (2011) · Wiley eBooks · doi:10.1002/9780470910016.ch16
Cortisol Metabolism in Type 2 Diabetes
Walker, B. R., & Andrew, R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030446
Kim, D. S., Park, Y.-S., Kim, S. H., Kim, Y., Jhee, O., Lee, S.-J., Kim, T.-W., & Kang, J.-S. (2011) · Eisei kagaku · doi:10.1248/jhs.57.378
Cortisol Metabolism and Glucose Intolerance
Kerstens, M. N., & Dullaart, R. P. F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030356
Tomlinson, J. (2009) · Clinical Lipidology · doi:10.2217/clp.09.31
Nutrigenómica aplicada a la obesidad
Aguilera, C. M., Olza, J., Gil‐Campos, M., Leis, R., Valle, M., Tojo, R., Cañete, R., & Gil, Á. (2011) · Revista Española de Nutrición Humana y Dietética · doi:10.1016/s2173-1292(11)70024-2
Bos, P. (2010) · Nottingham ePrints (University of Nottingham)
Hypothalamic-Pituitary-Adrenal Axis in Obese Chinese Children
Ho, A., Wong, E., Chan, I., & Nelson, E. A. S. (2008)
Katedra i Zakład Farmacji Fizycznej i Farmakokinetyki
Kosicka, K. (2011)
Kaltsas, G., & Chrousos, G. P. (2011) · Endocrine updates · doi:10.1007/978-1-4614-0011-0_5
Unravelling the link between insulin resistance and androgen excess
O’Reilly, M. (2015) · University of Birmingham Institutional Research Archive (University of Birmingham)
The metabolic syndrome as intrahepatocytic Cushing's syndrome
Vázquez, G. F., Torrecilla, E., & Rubio, M. Á. (2011) · Endocrinología y Nutrición (English Edition) · doi:10.1016/s2173-5093(11)70039-3
Korrelation zwischen Nebennierenmorphologie und kardiovaskulären Parametern
Reincke, M., & Beuschlein, F. (2015)
Compliance with an intense dietary intervention and glycemic control in type 2 diabetes
Eberly, L. N. (2015) · ResearchWorks at the University of Washington (University of Washington)
Long-term steroid hormone concentrations in healthy children, in obesity, and in disease
Noppe, G. (2016) · EUR Research Repository (Erasmus University Rotterdam)
Identification of microRNAs as potential novel regulators of HSD11B1 expression
Han, Y. (2012) · MACAU: Open Access Repository of Kiel University
de Sousa, D. W. N. (2011) · Americanae (AECID Library)
Dove, E. R. (2007) · UWA Profiles and Research Repository (University of Western Australia)
Metadata
- Authors
- Stewart, P. M., Boulton, A., Kumar, S., Clark, P. M. S., & Shackleton, C. H. L.
- Affiliations
- Queen Elizabeth Hospital Birmingham (GB)
- National Health Service (GB)
- Corresponding author
- Stewart, Paul M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1999-03
- Volume
- 84
- Issue
- 3
- Pages
- 1022-1027
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2165935278
- Cited by
- 398
- References
- 43
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 4 · 2022: 5 · 2021: 2 · 2020: 11 · 2019: 4 · 2018: 3 · 2017: 10 · 2016: 10 · 2015: 19 · 2014: 18 · 2013: 10 · 2012: 19
- FWCI
- 14.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- cortisol metabolism, abdominal obesity, cortisone to cortisol conversion, 11β-hydroxysteroid dehydrogenase type 1, urinary free cortisol, dexamethasone suppression, ACTH, body fat distribution, glucocorticoid metabolism, obesity pathogenesis, insulin resistance
- MeSH terms
- Adipose Tissue, Adult, Body Constitution, Cortisone, Female, Humans, Hydrocortisone, Male, Obesity, Tetrahydrocortisol, Tetrahydrocortisone, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.